Instil Bio

R&D company developing tumor infiltrating lymphocytes (TIL) for the treatment of solid tumor cancers

placeManchester, England, United Kingdom calendar_todayFounded 2018 groups23 employees language instilbio.com

Registered entities

Investor mix

3 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital133%
Private equity267%
Coming soon